Jump Financial’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$211K Sell
28,900
-162,966
-85% -$1.54M ﹤0.01% 2101
2026
Q2
$2.08M Buy
191,866
+165,421
+626% +$1.89M 0.02% 877
2026
Q1
$294K Buy
26,445
+9,037
+52% +$114K ﹤0.01% 1495
2025
Q4
$289K Buy
+17,408
New +$249K ﹤0.01% 1581

Other funds holding PHAT

Jump Financial's PHAT Position: Q3 2026 in Review

Jump Financial reduced its Phathom Pharmaceuticals (PHAT) stake by 85% in Q3 2026, selling an estimated $1.54M and leaving 28,900 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #2101.

Jump Financial first reported a position in PHAT in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.08M in Q2 2026. 161 funds tracked by Wall St. Rank hold PHAT as of Q3 2026.

  • Jump Financial held 28,900 shares of Phathom Pharmaceuticals worth $211K as of Q3 2026.
  • Jump Financial sold 162,966 Phathom Pharmaceuticals shares in Q3 2026, an estimated $1.54M.
  • Phathom Pharmaceuticals made up ﹤0.01% of Jump Financial's portfolio in Q3 2026, its #2101 holding.
  • Jump Financial first reported a position in Phathom Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Jump Financial's Phathom Pharmaceuticals position peaked at $2.08M in Q2 2026.
  • 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.